Loading...

Doctors Tell Senate Pandemic Deaths Preventable With Early Treatments

November 19, 2020 by Tom Ramstack
Doctors Tell Senate Pandemic Deaths Preventable With Early Treatments
People stand in line to being tested at the COVID-19 mobile testing facility at Miami Beach Convention Center in Miami Beach, Fla. (David Santiago/Miami Herald via AP)

WASHINGTON — Medical experts told a Senate committee Thursday that misguided information about early treatment contributed to giving the United States the world’s highest death rate from coronavirus.

Some of them blamed the Food and Drug Administration for halting a treatment they say could have reduced the death toll far below the current rate that topped a quarter million this week.

“It’s grossly overlooked,” said Peter A. McCullough, vice chief of internal medicine at Baylor University Medical Center.

He recommended treating COVID-19 patients as soon as they show symptoms with a cocktail of cortical steroids, blood thinners and a controversial drug called Hydroxychloroquine.

“This cocktail of drugs works for sure,” said McCullough, who was infected with COVID-19 but recovered after taking Hydroxychloroquine.

He warned that waiting for vaccines that will become commonly available sometime in mid-2021 could be disastrous.

“In a matter of weeks to months, Americans are going to be horrified by what they see on the news,” McCullough told the Senate Homeland Security and Governmental Affairs Committee.

Some medical forecasts show another 100,000 Americans could die from the disease by January. More than 11.5 million Americans have been infected, according to Johns Hopkins University data.

Much of the controversy during the Senate hearing focused on the quality of scientific studies that either show Hydroxychloroquine is an effective treatment or potentially dangerous. Three medical experts said the studies show it is worthwhile while one said different data demonstrated it provided no benefit to patients.

President Donald Trump last Spring recommended Hydroxychloroquine as an early treatment for COVID-19. He said he was taking it himself as a preventive measure.

However, in July the Food and Drug Administration issued a warning that Hydroxychloroquine was a waste of time for COVID-19. The warning added that the inexpensive, readily-available drug could cause heart attacks with prolonged use.

Sen. Ron Johnson, R-Wisc., blamed politics rather than medical science as the barrier to early treatment with Hydroxychloroquine and other medicines. He called the failure of the Food and Drug Administration to authorize the treatments “this glaring blunder that has cost far too many lives.”

“There’s something wrong here,” Johnson said as he pledged to investigate further. He chairs the Homeland and Governmental Affairs Committee.

Johnson suggested the Food and Drug Administration might have issued its warning about Hydroxychloroquine partly because of opposition to Trump’s policies.

He also asked whether the relatively small cost of the drug at about $20 per dose might have created political pressure to suppress it. Other drugs produced by American pharmaceutical companies that are used to treat COVID-19 can cost as much as $3,000 per treatment, he said.

The strongest opposition to treatment with Hydroxychloroquine or anything other than the currently approved therapies came from Ashish K. Jha, dean of Brown University’s School of Public Health.

“Hydroxychloroquine provides no benefit in treating COVID-19,” Jha said.

Unscientific studies led to “conspiracy” theories that misled some doctors about the effectiveness of the drug, he said.

Until vaccines scheduled for widespread distribution next year become available, he suggested standard prevention methods. They include wearing masks, social distancing, opening windows for fresh air and cleanliness.

He tried to debunk disputes over Hydroxychloroquine by saying they were driven by political disagreement rather than confusion over scientific studies reviewed by thousands of doctors.

“Pulling off a conspiracy like that would be extremely difficult,” Jha said.

In The News

Health

Voting

Health

January 14, 2022
by Dan McCue
White House Announces Plans to Distribute Home COVID Tests

WASHINGTON — Beginning Jan. 19, Americans will be able to order free at-home COVID-19 tests online from the federal government,... Read More

WASHINGTON — Beginning Jan. 19, Americans will be able to order free at-home COVID-19 tests online from the federal government, a senior White House official announced Friday afternoon. In the early going of the new program, individuals will be limited to four free tests per residential... Read More

Mask Rules Get Tighter in Europe in Winter's COVID-19 Wave

ROME (AP) — To mask or not to mask is a question Italy settled early in the COVID-19 outbreak with... Read More

ROME (AP) — To mask or not to mask is a question Italy settled early in the COVID-19 outbreak with a vigorous “yes." Now the onetime epicenter of the pandemic in Europe hopes even stricter mask rules will help it beat the latest infection surge. Other... Read More

January 12, 2022
by Reece Nations
House Rules Committee Rejects G.I. Bill Education Benefits for Vaccine Refusal

WASHINGTON — The House Rules Committee on Monday rejected an amendment to the Guard and Reserve G.I. Bill Parity Act... Read More

WASHINGTON — The House Rules Committee on Monday rejected an amendment to the Guard and Reserve G.I. Bill Parity Act that would guarantee Armed Services members discharged for refusing the COVID-19 vaccine are eligible for G.I. Bill education benefits. The Guard and Reserve G.I. Bill Parity... Read More

January 12, 2022
by Alexa Hornbeck
Reliability of Antigen Rapid Tests in Detecting Early Omicron Questioned

WASHINGTON — Beginning Jan. 15, private health insurers will be required to cover the cost of home testing kits despite... Read More

WASHINGTON — Beginning Jan. 15, private health insurers will be required to cover the cost of home testing kits despite recent concerns from elected officials and researchers over the reliability and availability of rapid antigen testing. “I’ve heard from so many people who are waiting in... Read More

January 12, 2022
by Alexa Hornbeck
COVID Pills Show Promise for Combating Severe Infection

Pfizer’s Paxlovid is the first pill treatment to combat severe COVID-19 infection, and new figures from Israel’s Ministry of Health... Read More

Pfizer’s Paxlovid is the first pill treatment to combat severe COVID-19 infection, and new figures from Israel’s Ministry of Health show the pill may hold promise in saving lives. Shortly before Christmas Day, Paxlovid was authorized for at-home treatment of high-risk COVID-19 infections in patients over... Read More

January 12, 2022
by Alexa Hornbeck
Researchers Develop mRNA-based Lyme Disease Vaccine

Yale researchers recently developed an mRNA-based Lyme disease vaccine capable of targeting antigens in tick saliva to prevent their ability... Read More

Yale researchers recently developed an mRNA-based Lyme disease vaccine capable of targeting antigens in tick saliva to prevent their ability to transmit pathogens.  According to the CDC, nearly half a million people in the U.S. are diagnosed with Lyme Disease every year. The ailment is most... Read More

News From The Well
Exit mobile version